CEO of San Antonio urology group steps down

Article

Juan A. Reyna, MD, who has served as president and CEO of Urology San Antonio for 16 years, has stepped down as the leader of the 29-physician group. He will continue to work as a urologist at the medical practice.

Juan A. Reyna, MD, who has served as president and CEO of Urology San Antonio for 16 years, has stepped down as the leader of the 29-physician group. He will continue to work as a urologist at the medical practice.

Clayton H. Hudnall, MD, Urology San Antonio’s vice president, will serve as interim president and CEO until the group selects a new physician leader next year, the practice said in a statement.

"It has been a privilege to serve with so many wonderful people. I’m proud of what we’ve accomplished together over the years, growing Urology San Antonio into an organization that other groups study as a model," Dr. Reyna said. "This has been a difficult decision, but I’m looking forward to exploring new challenges and opportunities."

Dr. Reyna completed his residency at the University of Texas Health Science Center at San Antonio in 1981. In July that year, he opened his practice as a solo urologist in downtown San Antonio. By 1996, the practice had grown to seven urologists. That year, it merged with another local urology group to form Urology San Antonio.

Dr. Reyna has served as the president and CEO of the group since its founding. Today, the practice includes 28 urologists, a radiation oncologist, nine clinic locations, and approximately 200 employees.

Dr. Reyna is also president-elect of the Large Urology Group Practice Association.

Go back to this edition of Urology Times Conference Brief.

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.